S. 2737 · 118th Congress
FDA Review of Efficacy of EERW Double-Blinds of Opioids Act
- Stage
- In committee
- Sponsor
- Joe Manchin
- Introduced
- 2023-09-07
- Latest action
- 2023-09-07 · Introduced in Senate
Subjects
Health
S. 2737 · 118th Congress